Nano X Imaging Ltd - Asset Resilience Ratio
Nano X Imaging Ltd (NNOX) has an Asset Resilience Ratio of 7.17% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how Nano X Imaging Ltd's Asset Resilience Ratio has changed over time. Check Nano X Imaging Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Nano X Imaging Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Nano X Imaging Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.46 Million | 7.17% |
| Total Liquid Assets | $10.46 Million | 7.17% |
Asset Resilience Insights
- Limited Liquidity: Nano X Imaging Ltd maintains only 7.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nano X Imaging Ltd Industry Peers by Asset Resilience Ratio
Compare Nano X Imaging Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Nano X Imaging Ltd (2020–2025)
The table below shows the annual Asset Resilience Ratio data for Nano X Imaging Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.45% | $10.46 Million | $162.16 Million | -9.69pp |
| 2024-12-31 | 16.14% | $33.90 Million | $210.00 Million | +4.25pp |
| 2023-12-31 | 11.89% | $26.01 Million | $218.65 Million | -3.53pp |
| 2022-12-31 | 15.42% | $39.16 Million | $253.93 Million | +9.35pp |
| 2021-12-31 | 6.08% | $22.07 Million | $363.17 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $236.15 Million | -- |
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source… Read more